We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JBH:ASXJB Hi-Fi Limited Analysis

Data as of 2026-07-19 - not real-time

A$79.81

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

JB Hi‑Fi is trading at AUD 79.81, just above its 20‑day SMA (78.83) and comfortably above the 50‑day SMA (75.65) but still well under the 200‑day SMA (86.25), indicating short‑term momentum but a longer‑term downtrend. The RSI of 56.96 signals a neutral stance while the MACD histogram is negative and the signal line is bearish, and volume has been trending lower, suggesting limited upside in the near term. Volatility is elevated at roughly 27% over the past 30 days, yet the computed beta of 0.30 points to low systematic market risk. Recent broker activity has trimmed ratings on JB Hi‑Fi, adding a modest bearish bias to the technical picture. Fundamentally, the company posted 7.3% revenue growth, a solid ROE of 29%, and generates strong cash flow, supporting its 3.95% dividend yield with a 62% payout ratio. The stock trades at a forward P/E of 17.6 and a price‑to‑book of 5.2, placing it close to its DCF‑derived fair value of AUD 82.16 and the analyst median target of AUD 82.9, implying limited upside. Given the blend of modest valuation, attractive dividend, and robust profitability, the investment case leans toward a stable, income‑focused position rather than aggressive growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Recent broker rating downgrades
  • Price near short‑term moving averages with limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 7.3% revenue growth and strong ROE (29%)
  • Attractive 3.95% dividend yield with sustainable payout
  • Fair valuation near DCF fair value and analyst median target

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent cash generation and dividend sustainability
  • Low beta indicating defensive characteristics
  • Cyclical consumer exposure balanced by strong balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin4.40%
P/E Ratio18.1
ROE29.24%
ROA10.69%
Debt/Equity43.39
P/B Ratio5.2
Op. Cash FlowA$665.1M
Free Cash FlowA$519.5M

Technical Analysis

TrendNeutral
RSI57.0
SupportA$75.25
ResistanceA$83.60
MA 20A$78.83
MA 50A$75.65
MA 200A$86.25
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueA$82.16
Target PriceA$79.48
Upside/Downside-0.42%
GradeFair
TypeBlend
Dividend Yield3.95%

Risk Assessment

Beta0.30
Volatility26.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.